Analyst Ratings for SAB Biotherapeutics (SABS)
SABS Rating Summary
SABS Price Target Summary
- Highest: $15.00 (Guggenheim)
- Lowest: $6.00 (Craig-Hallum)
- Average: $10.45
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$10.45 (+161.4%)
* Over Last 12-Mos
Rating Score: 9.3 / 10
Percentile Rank: 90%
Rating Score: 9.3 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/22/2026 | Citi | Samantha Semenkow | New Coverage | Buy (N/A) |
11.00 (N/A) |
3.81 (4.00) |
4.99% | Details |
| 5/20/2026 | Jefferies » Updated 6/15/2026 |
Roger Song | New Coverage | Buy (N/A) |
13.00 (11.00) |
3.56 (4.00) |
12.36% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
